Reports Outline Liver Cancer Findings from Seoul National University (Effectiveness of Lenvatinib Versus Sorafenib for Unresectable Hepatocellular Carcinoma In Patients With Hepatic Decompensation)

Press/Media

Period30 Oct 2023

Media coverage

1

Media coverage

  • TitleReports Outline Liver Cancer Findings from Seoul National University (Effectiveness of Lenvatinib Versus Sorafenib for Unresectable Hepatocellular Carcinoma In Patients With Hepatic Decompensation)
    Media name/outletSouth Korea Daily Report
    Country/TerritoryUnited States
    Date30/10/23
    PersonsKyung Sun Park
View all 1
View less